Target intelligence / Profile preview

Off-target messenger RNA with partial seed complementarity (Seed-mediated off-targets)

Target
Seed-mediated off-targets
Molecular classification
Nucleic acid, Other
01

Overview

Off-target mRNAs with partial seed complementarity represent a significant challenge in the development of RNA interference (RNAi) and antisense therapies. This phenomenon occurs when the seed region of a small interfering RNA (siRNA) or microRNA—typically nucleotides 2 through 8—binds to unintended messenger RNA (mRNA) transcripts that possess complementary sequences, usually in their 3' untranslated regions (UTRs) [Jackson et al., 2003, Nature Biotechnology]. This binding mimics the natural regulatory mechanism of endogenous microRNAs, leading to the degradation or translational repression of these non-target genes [Birmingham et al., 2006, Nature Methods]. Because a single 6-7 nucleotide sequence can appear in hundreds of different mRNAs, a single siRNA can potentially perturb the expression of many genes, leading to unintended biological consequences and potential toxicity [Fedovov et al., 2006, RNA]. Strategies to mitigate these effects include chemical modifications of the siRNA backbone, such as 2'-O-methyl substitutions at position 2 of the guide strand, and the use of bioinformatic algorithms to select sequences with minimal off-target potential [Jackson et al., 2006, RNA]. Understanding and predicting these interactions is crucial for ensuring the safety and specificity of oligonucleotide-based drugs [Burchard et al., 2009, Nature Biotechnology].

Other names
miRNA-like off-target effectsSeed-based off-targetsUnintended mRNA silencingSeed-mediated off-target effects
02

Mechanism of action

Seed-mediated sequence recognition where the 5' end of an siRNA or miRNA guide strand (nucleotides 2-8) binds to partially complementary sequences in the 3' UTR of unintended mRNAs, leading to RISC-mediated degradation or translational repression [Jackson et al., 2003, Nature Biotechnology; Birmingham et al., 2006, Nature Methods].

03

Biological functions

Post-transcriptional regulationRNA interferenceTranslation inhibitionOther
04

Disease associations

Other
05

Safety considerations

HepatotoxicityUnintended gene silencingOff-target toxicitySaturation of the RNAi machineryImmune activation
06

Interacting drugs

Patisiran

4 more in the full profile.

07

Biomarkers

Transcriptome profiling (RNA-seq)Microarray analysisDual-luciferase reporter assays

Beyond the preview

Go deeper on Off-target messenger RNA with partial seed complementarity (Seed-mediated off-targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target messenger RNA with partial seed complementarity (Seed-mediated off-targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call